Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase NA 1

Status

Completed 9Unknown 5Terminated 5Active not recruiting 4Recruiting 3Not yet recruiting 3Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 22Carboplatin 15Radiotherapy 13Paclitaxel 11Gemcitabine 10Rituximab 9Fluorouracil 9Drug Therapy 6Dexamethasone 5Cyclophosphamide 5Capecitabine 5Bevacizumab 5Vinorelbine 4Pemetrexed 4Nivolumab 4Methotrexate 4Etoposide 4Docetaxel 4Bendamustine Hydrochloride 4spartalizumab 3pertuzumab 3pembrolizumab 3fludarabine 3Vincristine 3Trastuzumab 3Surgical Procedures, Operative 3Standard of Care 3Prednisone 3Oxaliplatin 3Lenalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Withdrawn × Aspirin × Clear all
NCT02326779 2021-04-27

Low-dose Aspirin Therapy for Esophageal Cancer

Zhejiang University

Phase 3 Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT01058902 2016-03-07

The Effect Of Aspirin On Survival in Lung Cancer

Liverpool Heart and Chest Hospital NHS Foundation Trust

Phase 3 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡